Pfizer’s peak COVID sales now pegged at $50B-plus, with vaccine still hauling in $25B by 2027: analysts
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
December 16, 2021 at 04:57PM
Pfizer’s peak COVID sales now pegged at $50B-plus, with vaccine still hauling in $25B by 2027: analysts
Welcome to vaccine education 